We have collected information about Alkermes Drug Delivery for you. Follow the links to find out details on Alkermes Drug Delivery.
Alkermes plc is a pharmaceutical manufacturing and biopharmaceutical company developing innovative medicines to help patients with serious chronic conditions.
https://www.alkermes.com/products
In particular, Alkermes is focused on drug development for central nervous system (CNS) diseases, a therapeutic area where we have a proven track record. Our aim is to develop new medicines that make significant advances for chronic CNS conditions that affect millions of patients, such as schizophrenia,...
https://www.marketwatch.com/press-release/global-monoclonal-antibodies-drug-delivery-market-2020-alkermes-johnson-johnson-heron-janssen-biotech-eisai-2020-01-22
Jan 22, 2020 · The post Global Monoclonal Antibodies Drug Delivery Market 2020 – Alkermes , Johnson & Johnson , Heron , Janssen Biotech , Eisai appeared first on America News Hour.
https://www.fiercepharma.com/drug-delivery/alkermes-wraps-buyout-of-elan-drug-delivery-biz
Sep 19, 2011 · Some of the key products that use Alkermes' drug-delivery systems include Risperdal, a long-acting schizophrenia drug, and Bydureon, a diabetes med.
https://xconomy.com/boston/2018/10/30/fda-blasts-data-trial-design-for-alkermes-depression-drug/
That’s why shares of Alkermes, a company best known for its roots as a drug delivery specialist, have had such huge swings on updates to the ALKS-5461 program. And those swings should continue ...
https://www.nytimes.com/topic/company/alkermes-inc
Alkermes Inc is granted two patents covering sustained-release form of erythropoietin, drug known as EPO, which stimulates growth of red blood cells; it was originally developed for patients on dialysis, but can also be used to increase oxygen capacity of endurance athletes;
https://www.fiercepharma.com/drug-delivery/alkermes-elan-deal-forms-well-positioned-drug-delivery-company
May 11, 2011 · It was Alkermes' drug-delivery technology that drove Bydureon, although it was not clear whose technology, exactly, was responsible for the possible irregular heartbeats that caused the drug's rejection. Vivitrol, which treats alcohol dependence, also employs Alkermes' drug delivery technology.
https://www.alkermes.com/research-and-development/pipeline
Alkermes rich CNS drug development candidate pipeline is streamlined by decades of experience, increasing the likelihood of late-stage commercial success. Home Contact Us
https://www.alkermes.com/products/proprietary-products-and-technologies
Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature.
https://www.alkermes.com/research-and-development/technology-platforms
Alkermes has established R&D experience as well as expertise in the molecular biology of opioid receptors. Opioid receptors present opportunities for disease intervention in addiction, behavior and mood modification, immunology, and pain. Our drug development scientists are applying a …
Searching for Alkermes Drug Delivery?
You can just click the links above. The data is collected for you.
